Stay updated on De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial
Sign up to get notified when there's something new on the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page.

Latest updates to the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page
- Check3 days agoChange DetectedThe page’s revision tag was updated from v3.6.0 to v3.6.2, indicating a minor update to the page. No substantive content changes to the study details are introduced.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedAdded recruitment status notice and new help/navigation items such as 'How to Read a Study Record', 'Common Questions', 'How to Join a Study', and 'Intervention/Treatment', with a page revision update to v3.6.0; the old 'Intervention / Treatment' label was removed.SummaryDifference0.3%

- Check25 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a small internal update to the page; the study details remain the same.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a new version of the page content was published.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision label updated from v3.5.2 to v3.5.3 on the page. This reflects a backend/template maintenance update and does not alter study details shown to users.SummaryDifference0.0%

- Check75 days agoChange DetectedSite revision updated to v3.5.2, replacing the previous v3.5.0.SummaryDifference0.0%

Stay in the know with updates to De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page.